Drug intelligence / Profile preview

TrisanAF

Development stage: Unknown
Lead developer: V Pharma
Modality: Small Molecules
Administration: Topical

Overview

**TrisanAF** is a Vpharma alcohol-free topical hand-sanitiser gel containing the antiseptic agents chlorhexidine digluconate and cetrimide in a moisturising aqueous base with aloe vera. The formulation is intended for hand hygiene and reduction of microbial transmission when soap and water are unavailable. Its cationic antiseptic ingredients act broadly against microorganisms through disruption of microbial cell membranes; Vpharma states that the product conforms with BS EN 1276 and BS EN 1500 standards and is active against common organisms including MRSA, *Clostridioides difficile*, and *Escherichia coli*.

Brand names: TrisanAF
Other names: TrisanAF Alcohol Free Hand Sanitiser GelTrisanAF Hand Sanitiser

Beyond the preview

Go deeper on TrisanAF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TrisanAF.

Explore the full profile